-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GSaPO/qll5//FuAsrba3DQw3POr03IiGPs4yjWt+tSPVQ8LD+IkWc4l+PtR++kV1 l+sCzMRsugShXXbJPY09Zg== 0001181431-11-005459.txt : 20110127 0001181431-11-005459.hdr.sgml : 20110127 20110127114625 ACCESSION NUMBER: 0001181431-11-005459 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100226 FILED AS OF DATE: 20110127 DATE AS OF CHANGE: 20110127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gionco David CENTRAL INDEX KEY: 0001456864 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 11551176 MAIL ADDRESS: STREET 1: 9 HOWELL DRIVE CITY: FAR HILLS STATE: NJ ZIP: 07931 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 rrd298830.xml DAVID GIONCO FORM 4 X0303 4 2010-02-26 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001456864 Gionco David SAVIENT PHARMACEUTICALS, INC. ONE TOWER CENTER, 14TH FLOOR EAST BRUNSWICK NJ 08816 0 1 0 0 Group VP & CFO Common Stock, $0.01 par value per share 2010-02-26 4 A 0 144 11.4495 A 44563 D Common Stock, $0.01 par value per 2010-05-31 4 A 0 71 10.2340 A 44634 D Common Stock, $0.01 par value per 2010-08-31 4 A 0 60 11.9510 A 44694 D Common Stock, $0.01 par value per 2010-11-30 4 A 0 73 10.0300 A 44767 D Common Stock, $0.01 par value per 2011-01-24 4 S 0 2032 10.0000 D 42735 D Consists of shares acquired pursuant to the Savient Pharmaceuticals, Inc. 1998 Employee Stock Purchase Plan, which were not previously reported on a Form 4. These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934, to cover tax withholding obligations in connection with the vesting of restricted stock granted on January 22, 2007. /s/ Irina Ishak as Attorney-In-Fact for David Gionco 2011-01-26 -----END PRIVACY-ENHANCED MESSAGE-----